Pharmaceuticals Government Tenders in Denmark

Registration, quality assurance and the shape of a medicines contract

A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.

Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.

The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.

This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.

Who buys pharmaceuticals in Denmark?

GlobalGov holds 355 pharmaceuticals records from 65 distinct buying organisations in Denmark. The most frequent publishers are Amgros I/S (104 records); Amgros I/S (29 records); Socialstyrelsen (19 records); Statens Serum Institut (7 records); Biofos A/S (5 records); Guldborgsund Forsyning A/S (5 records). Between them the 6 largest account for 48% of everything published, so buying here is spread across many separate authorities.

What are pharmaceuticals contracts worth in Denmark?

233 of the 355 records publish a contract value. The median is $4.2M and the largest single published value is $345.2M. By size, 6 under $100k, 42 between $100k and $1M, 107 between $1M and $10M, 78 above $10M. The remaining 122 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.

How long do bidders get to respond to pharmaceuticals tenders in Denmark?

Across the 75 Denmark pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 34 days. A quarter of them allowed 30 days or fewer and a quarter stayed open for more than 42. Not one of them closed within a fortnight of being published, so the window on this market is consistently workable.

How often are pharmaceuticals tenders published in Denmark?

Denmark publishes about 12 notices a month in this category, 144 in the last twelve months. That is 1340% more than the 10 published in the twelve months before that. Over the last three years there were 188, spread across 49 separate months of activity since 11 August 2016. May is historically the busiest month. The most recent was published 14 September 2026.

How does Denmark compare with other pharmaceuticals markets?

Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Denmark ranks 18th by number of records. The largest is Germany (4,115 records against 355 here). Within Denmark itself, pharmaceuticals is the 8th largest of the 43 procurement categories tracked here.

Where do the Denmark pharmaceuticals records on this page come from?

These 355 records are collected from 2 official sources: TED (354), Doffin (1). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.

Open Pharmaceuticals tenders in Denmark

Showing 10 of the 19 notices open in this category today. Openness uses the same definition as the Denmark market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.

Other procurement categories in Denmark

Pharmaceuticals procurement in other markets